September is GYN Cancers Month

gyn_septSeptember is set aside to raise awareness of gynecological cancers.  GYN cancers affect women’s reproductive organs including the cervix, endometrium, uterus, fallopian tubes, vagina, vulva, and ovaries.

In 2009 there will be an estimated 80,720 new cases of GYN cancers and 28,120 deaths.

Women with Lynch syndrome (also known as hereditary non-polyposis colon cancer or HNPCC)  have a high lifetime risk of endometrial cancer, reaching 71 percent by the age of 70.  This is much higher than the general population whose risk is less than 2 percent.

Lynch syndrome women also have a 10 to 12 percent lifetime risk of ovarian cancer, again larger than the other women with a risk is about 1.5 percent.

Women who have been identified as carrying one of the Lynch syndrome genes — MLH1, MSH2, MSH6, or PMS2 — should plan annual screening for both ovarian and endometrial cancer beginning about age 30 to 35.  A pelvic-rectal examination, transvaginal ultrasound, CA-125 blood test, and endometrial biopsy should be part of that exam.

On the other hand, women who are diagnosed with endometrial cancer before menopause or the age of 50 are at high risk for Lynch syndrome and colorectal cancer.  They should consider genetic counseling and testing.  Tumor testing may identify older women who need further genetic testing, as well.

Symptoms of endometrial cancer that should prompt a visit to a gynecologist and endometrial biopsy include:

Symptoms of ovarian cancer can be subtle, but according to the Ovarian Cancer National Alliance, they are more likely to occur in women with ovarian cancer than other women.  They exist even in early stages.  When symptoms are persistent and are a change from a woman’s normal patterns, they should be investigated.  Symptoms include:

Cervical cancer is not part of the Lynch syndrome.  However, all women should schedule regular pap smears to detect changes in cells that may lead to cervical cancer.  Such screening can prevent cervical cancer. However, pap smears do not detect or prevent ovarian or endometrial cancer.

Bookmark and Share

This news article was originally posted on August 31st, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on August 31st, 2009
Tags: endometrial cancer, Lynch syndrome, ovarian cancer

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe